1. FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5
   Kengo Takeda et al, 2024, International Journal of Molecular Sciences CrossRef
2. Calcium influx, oxidative stress, and apoptosis induced by TRPV1 in chronic myeloid leukemia cells: Synergistic effects with imatinib
   Federica Maggi et al, 2023, Frontiers in Molecular Biosciences CrossRef
3. The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
   Shaun David Patterson et al, 2023, Current Hematologic Malignancy Reports CrossRef